España
Acceder
Cotización de Alpine Immune Sciences, Inc. (ALPN) hoy en tiempo real
Análisis técnico y gráfico histórico de Alpine Immune Sciences, Inc.
Análisis fundamental y estadísticas clave de Alpine Immune Sciences, Inc.
Ficha de Alpine Immune Sciences, Inc. (ALPN)
| Ticker | ALPN |
|---|---|
| ISIN | US02083G1004 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Alpine Immune Sciences, Inc.
Resumen financiero e información corporativa de Alpine Immune Sciences, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Alpine Immune Sciences, Inc.
Márgenes de rentabilidad y Cash Flow de Alpine Immune Sciences, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Alpine Immune Sciences, Inc.
Solvencia y deuda: Análisis del balance de Alpine Immune Sciences, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Alpine Immune Sciences, Inc.
Invertir en Alpine Immune Sciences, Inc. en 2026: Preguntas frecuentes
¿Qué es Alpine Immune Sciences, Inc.?
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibito...
¿En qué sector opera Alpine Immune Sciences, Inc.?
Alpine Immune Sciences, Inc. opera en el sector Healthcare, industria Biotechnology.